EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Autoantibodies against endothelial protein C receptor and integrin αvβ6 predict the development of ulcerative colitis

Motoi Sawahashi, Yoichi Kakuta, Takeo Naito, Soshi Okazaki, Kinuko Ohneda, Masatsugu Orui, Taku Obara, Soichi Ogishima, Kazuki Kumada, Hisaaki Kudo, Fuji Nagami, Atsushi Hozawa und 9 weitere

Journal of Gastroenterology · 2025

DOI: 10.1007/s00535-025-02263-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology, 2025. Verfasst von Motoi Sawahashi und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1, Seiryo, Aoba-Ku, Sendai, Miyagi, 980-8574, Japan. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Autoantibodies, Integrins, Endothelial Protein C Receptor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A method for predicting ulcerative colitis (UC) onset has not been established. Serum autoantibodies have been suggested as potential predictive biomarkers for UC onset. We aimed to validate the risks associated with serological and environmental factors and construct a model for predicting UC development.

Methods

Using the population-based cohort studies ( n > 83,000), we identified 42 individuals who were diagnosed with UC later in life and compared them with matched healthy controls. We analyzed serum anti-integrin αvβ6 antibody (anti-αvβ6) and anti-endothelial protein C receptor antibody (anti-EPCR) titers, and lifestyle and dietary habits to explore UC onset predictors. The predictive performance of the models was evaluated based on these predictors.

Results

The sensitivity and specificity of anti-EPCR for predicting UC onset were 51.4% and 97.8%, respectively, comparable to those of anti-αvβ6 (52.5% and 97.6%, respectively). The proportion of individuals with insomnia was significantly higher in the preclinical UC group (adjusted odds ratio = 2.14, 95% confidence interval [CI] 1.11–4.04, p = 0.019). The predictive performance of anti-EPCR alone was high with an area under the curve (AUC) of 0.89 (95%CI 0.83–0.96), and that of anti-EPCR combined with anti-αvβ6 was even better with an AUC of 0.92 (95%CI 0.87–0.97); the lifestyle model had lower predictive accuracy (AUC = 0.65, 95%CI 0.55–0.74).

Conclusions

Anti-EPCR and anti-αvβ6 each strongly predict UC onset. The combined anti-EPCR and anti-αvβ6 model had stronger predictive performance than the single models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeAutoantibodiesIntegrinsEndothelial Protein C ReceptorAntigens, CDHumansMaleFemaleMiddle AgedAdultBiomarkersPredictive Value of TestsSensitivity and SpecificityCase-Control StudiesCohort StudiesRisk FactorsAgedLife StyleYoung AdultAntigens, Neoplasm

Stichwörter der Autor:innen

Anti-EPCR antibodyAnti-integrin αvβ6 antibodyUlcerative colitis

Substanzen

AutoantibodiesBiomarkersIntegrinsEndothelial Protein C Receptorintegrin alphavbeta6Antigens, CDAntigens, Neoplasm

Autor:innen und Institutionen

  • Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1, Seiryo, Aoba-Ku, Sendai, Miyagi, 980-8574, Japan.
  • Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1, Seiryo, Aoba-Ku, Sendai, Miyagi, 980-8574, Japan. ykakuta@tohoku.ac.jp.
  • Department of Rheumatology, Tohoku University Hospital, Sendai, Japan.
  • Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
  • Advanced Research Center for Innovations in Next-Generation Medicine, Tohoku University, Sendai, Japan.
  • Division of Disaster Public Health, International Research Institute of Disaster Science, Tohoku University, Sendai, Japan.

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology
  • Japan Agency for Medical Research and Development

Zitieren

APA

Sawahashi, M., Kakuta, Y., Naito, T., Okazaki, S., Ohneda, K., Orui, M., Obara, T., Ogishima, S., Kumada, K., Kudo, H., Nagami, F., Hozawa, A., Iwaki, H., Nagai, H., Shimoyama, Y., Moroi, R., Shiga, H., Kinouchi, Y., Shirai, T., …, & Masamune, A. (2025). Autoantibodies against endothelial protein C receptor and integrin αvβ6 predict the development of ulcerative colitis. Journal of Gastroenterology. https://doi.org/10.1007/s00535-025-02263-7

Vancouver

Sawahashi M, Kakuta Y, Naito T, Okazaki S, Ohneda K, Orui M, et al. Autoantibodies against endothelial protein C receptor and integrin αvβ6 predict the development of ulcerative colitis. Journal of Gastroenterology. 2025. doi:10.1007/s00535-025-02263-7

BibTeX
@article{Sawahashi2025,
  author = {Sawahashi, Motoi and Kakuta, Yoichi and Naito, Takeo and Okazaki, Soshi and Ohneda, Kinuko and Orui, Masatsugu and Obara, Taku and Ogishima, Soichi and Kumada, Kazuki and Kudo, Hisaaki and Nagami, Fuji and Hozawa, Atsushi and Iwaki, Hideya and Nagai, Hiroshi and Shimoyama, Yusuke and Moroi, Rintaro and Shiga, Hisashi and Kinouchi, Yoshitaka and Shirai, Tsuyoshi and Fujii, Hiroshi and Masamune, Atsushi},
  title = {Autoantibodies against endothelial protein C receptor and integrin αvβ6 predict the development of ulcerative colitis},
  journal = {Journal of Gastroenterology},
  year = {2025},
  doi = {10.1007/s00535-025-02263-7}
}
Kostenlos starten →